LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
stringlengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
stringlengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
stringlengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
94250-8 | Borrelia burgdorferi oppA2 gene | PrThr | Pt | XXX | Ord | Non-probe.amp.tar | MICRO | 1 | Borrelia burgdorferi oppA2 gene [Presence] in Specimen by NAA with non-probe detection | B burgdorferi oppA2 Spec Ql NAA+non-prb | null | ACTIVE | 2.68 | 2.69 |
94251-6 | Borrelia mayonii oppA2 gene | PrThr | Pt | XXX | Ord | Non-probe.amp.tar | MICRO | 1 | Borrelia mayonii oppA2 gene [Presence] in Specimen by NAA with non-probe detection | B mayonii oppA2 Spec Ql NAA+non-probe | null | ACTIVE | 2.68 | 2.69 |
94252-4 | Borrelia garinii+afzelii oppA2 gene | PrThr | Pt | XXX | Ord | Non-probe.amp.tar | MICRO | 1 | Borrelia garinii+afzelii oppA2 gene [Presence] in Specimen by NAA with non-probe detection | B gar+afz oppA2 Spec Ql NAA+non-probe | null | ACTIVE | 2.68 | 2.69 |
94253-2 | Borrelia sp panel | - | Pt | XXX | - | Non-probe.amp.tar | PANEL.MICRO | 1 | Borrelia sp panel - Specimen by NAA with non-probe detection | B sp panel Spec NAA+non-probe | null | ACTIVE | 2.68 | 2.69 |
94254-0 | CYP1A2 gene product metabolic activity interpretation | Imp | Pt | Bld/Tiss | Ord | Molgen | MOLPATH.PHARMG | 1 | CYP1A2 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method | CYP1A2 gene prod met act Bld/T-Imp | null | ACTIVE | 2.68 | 2.68 |
94255-7 | Calcium | MCnc | Pt | Sweat | Qn | null | CHEM | 1 | Calcium [Mass/volume] in Sweat | Calcium Sweat-mCnc | null | ACTIVE | 2.68 | 2.68 |
94256-5 | Magnesium | MCnc | Pt | Sweat | Qn | null | CHEM | 1 | Magnesium [Mass/volume] in Sweat | Magnesium Sweat-mCnc | null | ACTIVE | 2.68 | 2.68 |
94257-3 | PROMIS pediatric - global health 7 - version 1.0 | - | Pt | ^Patient | - | PROMIS.PEDS | PANEL.SURVEY.PROMIS | 4 | PROMIS pediatric - global health 7 - version 1.0 | null | Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx | ACTIVE | 2.68 | 2.68 |
94258-1 | PROMIS pediatric - global health 7 - version 1.0 raw score | Score | Pt | ^Patient | Qn | PROMIS.PEDS | SURVEY.PROMIS | 4 | PROMIS pediatric - global health 7 - version 1.0 raw score | null | Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx | ACTIVE | 2.68 | 2.68 |
94263-1 | PROMIS pediatric - global health 7 - version 1.0 T-score | Tscore | Pt | ^Patient | Qn | PROMIS.PEDS | SURVEY.PROMIS | 4 | PROMIS pediatric - global health 7 - version 1.0 T-score | null | null | ACTIVE | 2.68 | 2.68 |
94264-9 | Brucella sp Ab | Titr | Pt | CSF | Qn | Aggl.capture | MICRO | 1 | Brucella sp Ab [Titer] in Cerebral spinal fluid by Immunocapture agglutination | Brucella Ab Titr CSF Capture aggl | null | ACTIVE | 2.68 | 2.69 |
94265-6 | Cells.CD18 | PrThr | Pt | Bld | Ord | null | CELLMARK | 1 | CD18 cells [Presence] in Blood | CD18 Cells Bld Ql | null | ACTIVE | 2.68 | 2.68 |
94266-4 | CD11a & CD11b & CD18 phenotyping panel | - | Pt | Bld | Ord | null | PANEL.CELLMARK | 1 | CD11a, CD11b, and CD18 phenotyping panel - Blood Qualitative | CD11a + CD11b + CD18 Pnl Bld | null | ACTIVE | 2.68 | 2.68 |
94267-2 | Cells.CD11b | PrThr | Pt | Bld | Ord | null | CELLMARK | 1 | CD11b cells [Presence] in Blood | CD11b Cells Bld Ql | null | ACTIVE | 2.68 | 2.68 |
9426-8 | Barbiturates | MCnc | Pt | Urine | Qn | null | DRUG/TOX | 1 | Barbiturates [Mass/volume] in Urine | Barbiturates Ur-mCnc | null | ACTIVE | 1.0i | 2.73 |
94268-0 | Cells.CD11a | PrThr | Pt | Bld | Ord | null | CELLMARK | 1 | CD11a cells [Presence] in Blood | CD11a Cells Bld Ql | null | ACTIVE | 2.68 | 2.68 |
94269-8 | Platelet aggregation.EPINEPHrine induced^50 umol/L | RelACnc | Pt | PRP | Qn | null | COAG | 1 | Platelet aggregation EPINEPHrine induced in Platelet rich plasma --50 umol/L | PA Epineph 50 umol/L PRP | null | ACTIVE | 2.68 | 2.68 |
94270-6 | Ubiquinone 10 | SCnt | Pt | WBC | Qn | null | CHEM | 1 | Coenzyme Q10 [Moles/mass] in Leukocytes | Ubiquinone10 WBC-sCnt | null | ACTIVE | 2.68 | 2.68 |
94271-4 | Purkinje cell cytoplasmic type 1 Ab.IgG | PrThr | Pt | Ser | Ord | Line blot | SERO | 1 | PCA-1 IgG Ab [Presence] in Serum by Line blot | PCA-1 IgG Ser Ql Line blot | null | ACTIVE | 2.68 | 2.68 |
94272-2 | Purkinje cell cytoplasmic type 1 Ab.IgG | PrThr | Pt | CSF | Ord | Line blot | SERO | 1 | PCA-1 IgG Ab [Presence] in Cerebral spinal fluid by Line blot | PCA-1 IgG CSF Ql Line blot | null | ACTIVE | 2.68 | 2.68 |
94273-0 | Muscle specific receptor tyrosine kinase Ab.IgG | SCnc | Pt | Ser | Qn | IA | SERO | 1 | Muscle specific receptor tyrosine kinase IgG Ab [Moles/volume] in Serum by Immunoassay | MuSK IgG Ser IA-sCnc | null | ACTIVE | 2.68 | 2.68 |
94274-8 | Bedaquiline | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Bedaquiline [Susceptibility] | Bedaquiline Susc Islt | null | ACTIVE | 2.68 | 2.68 |
94275-5 | Apis mellifera acid phosphatase recombinant (rApi m) 3 Ab.IgE | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Honey bee acid phosphatase recombinant (rApi m) 3 IgE Ab [Units/volume] in Serum | Honey bee (rApi m) 3 IgE Qn | null | ACTIVE | 2.68 | 2.68 |
9427-6 | Barbiturates | MCnc | Pt | Gast fld | Qn | null | DRUG/TOX | 1 | Barbiturates [Mass/volume] in Gastric fluid | Barbiturates Gast-mCnc | null | ACTIVE | 1.0i | 2.34 |
94276-3 | Apis mellifera dipeptidyl peptidase recombinant (rApi m) 5 Ab.IgE | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Honey bee dipeptidyl peptidase recombinant (rApi m) 5 IgE Ab [Units/volume] in Serum | Honey bee DPP (rApi m) 5 IgE Qn | null | ACTIVE | 2.68 | 2.68 |
94277-1 | Dog recombinant (rCan f) 6 Ab.IgE | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Dog recombinant 6 IgE Ab [Units/volume] in Serum | Dog (rCan f) 6 IgE Qn | null | ACTIVE | 2.68 | 2.68 |
94278-9 | Cat recombinant (rFel d) 7 Ab.IgE | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Cat recombinant (rFel d) 7 IgE Ab [Units/volume] in Serum | Cat (rFel d) 7 IgE Qn | null | ACTIVE | 2.68 | 2.68 |
94279-7 | Apis mellifera acid phosphatase recombinant (rApi m) 3 Ab.IgE.RAST class | PrThr | Pt | Ser | Ord | null | ALLERGY | 1 | Honey bee acid phosphatase recombinant (rApi m) 3 IgE Ab RAST class [Presence] in Serum | Honey bee (rApi m) 3 IgE RAST Ql | null | ACTIVE | 2.68 | 2.68 |
94280-5 | Apis mellifera dipeptidyl peptidase recombinant (rApi m) 5 Ab.IgE.RAST class | PrThr | Pt | Ser | Ord | null | ALLERGY | 1 | Honey bee dipeptidyl peptidase recombinant (rApi m) 5 IgE Ab RAST class [Presence] in Serum | Honey bee DPP (rApi m) 5 IgE RAST Ql | null | ACTIVE | 2.68 | 2.68 |
94281-3 | Dog recombinant (rCan f) 6 Ab.IgE.RAST class | PrThr | Pt | Ser | Ord | null | ALLERGY | 1 | Dog recombinant 6 IgE Ab RAST class [Presence] in Serum | Dog (rCan f) 6 IgE RAST Ql | null | ACTIVE | 2.68 | 2.68 |
94282-1 | Cat recombinant (rFel d) 7 Ab.IgE.RAST class | PrThr | Pt | Ser | Ord | null | ALLERGY | 1 | Cat recombinant (rFel d) 7 IgE Ab RAST class [Presence] in Serum | Cat (rFel d) 7 IgE RAST Ql | null | ACTIVE | 2.68 | 2.68 |
94283-9 | Dipeptidyl aminopeptidase-like protein 6 Ab.IgG | PrThr | Pt | CSF | Ord | CBA IFA | SERO | 1 | Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | DPPX IgG CSF Ql CBA IFA | null | ACTIVE | 2.68 | 2.69 |
9428-4 | Benzodiazepines | MCnc | Pt | Urine | Qn | null | DRUG/TOX | 1 | Benzodiazepines [Mass/volume] in Urine | Benzodiaz Ur-mCnc | null | ACTIVE | 1.0i | 2.73 |
94284-7 | Dipeptidyl aminopeptidase-like protein 6 Ab.IgG | Titr | Pt | CSF | Qn | IF | SERO | 1 | Dipeptidyl aminopeptidase-like protein 6 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence | DPPX IgG Titr CSF IF | null | ACTIVE | 2.68 | 2.68 |
94285-4 | Contactin-associated protein 2 Ab.IgG | PrThr | Pt | Ser | Ord | CBA IFA | SERO | 1 | Contactin-associated protein 2 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay | CASPR2 IgG Ser Ql CBA IFA | null | ACTIVE | 2.68 | 2.69 |
94286-2 | Contactin-associated protein 2 Ab.IgG | PrThr | Pt | CSF | Ord | CBA IFA | SERO | 1 | Contactin-associated protein 2 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | CASPR2 IgG CSF Ql CBA IFA | null | ACTIVE | 2.68 | 2.69 |
94287-0 | Leucine-rich glioma-inactivated protein 1 Ab.IgG | PrThr | Pt | Ser | Ord | CBA IFA | SERO | 1 | Leucine-rich glioma-inactivated protein 1 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay | LGI1 IgG Ser Ql CBA IFA | null | ACTIVE | 2.68 | 2.69 |
94288-8 | Leucine-rich glioma-inactivated protein 1 Ab.IgG | PrThr | Pt | CSF | Ord | CBA IFA | SERO | 1 | Leucine-rich glioma-inactivated protein 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay | LGI1 IgG CSF Ql CBA IFA | null | ACTIVE | 2.68 | 2.69 |
94289-6 | West Nile virus Ab.Neut | PrThr | Pt | XXX | Ord | Neut | MICRO | 1 | West Nile virus neutralizing antibody [Presence] in Specimen by Neutralization test | WNV NAb Spec Ql Nt | null | ACTIVE | 2.68 | 2.72 |
94290-4 | Saint Louis encephalitis virus Ab.Neut | PrThr | Pt | XXX | Ord | Neut | MICRO | 1 | Saint Louis encephalitis virus neutralizing antibody [Presence] in Specimen by Neutralization test | SLEV NAb Spec Ql Nt | null | ACTIVE | 2.68 | 2.72 |
94291-2 | Hydroxybupropion | PrThr | Pt | Ser/Plas | Ord | Screen | DRUG/TOX | 1 | Hydroxybupropion [Presence] in Serum or Plasma by Screen method | OH-bupropion SerPl Ql Scn | null | ACTIVE | 2.68 | 2.68 |
9429-2 | Indium | MCnc | Pt | XXX | Qn | null | DRUG/TOX | 1 | Indium [Mass/volume] in Specimen | Indium Spec-mCnc | null | ACTIVE | 1.0i | 2.7 |
94292-0 | Citalopram+Escitalopram | PrThr | Pt | Ser/Plas | Ord | Screen | DRUG/TOX | 1 | Citalopram+Escitalopram [Presence] in Serum or Plasma by Screen method | Citalopram+Escitalopram SerPl Ql Scn | null | ACTIVE | 2.68 | 2.68 |
94293-8 | Citalopram+Escitalopram | MCnc | Pt | Ser/Plas | Qn | Confirm | DRUG/TOX | 1 | Citalopram+Escitalopram [Mass/volume] in Serum or Plasma by Confirmatory method | Citalopram+Escitalopram SerPl Cfm-mCnc | null | ACTIVE | 2.68 | 2.68 |
94294-6 | Norcitalopram | PrThr | Pt | Ser/Plas | Ord | Screen | DRUG/TOX | 1 | Norcitalopram [Presence] in Serum or Plasma by Screen method | Norcitalopram SerPl Ql Scn | null | ACTIVE | 2.68 | 2.68 |
94295-3 | Duloxetine | PrThr | Pt | Ser/Plas | Ord | Screen | DRUG/TOX | 1 | DULoxetine [Presence] in Serum or Plasma by Screen method | DULoxetine SerPl Ql Scn | null | ACTIVE | 2.68 | 2.68 |
94296-1 | Norfluvoxamine | PrThr | Pt | Ser/Plas | Ord | Screen | DRUG/TOX | 1 | Norfluvoxamine [Presence] in Serum or Plasma by Screen method | Norfluvoxamine SerPl Ql Scn | null | ACTIVE | 2.68 | 2.68 |
94297-9 | Norfluvoxamine | MCnc | Pt | Ser/Plas | Qn | Confirm | DRUG/TOX | 1 | Norfluvoxamine [Mass/volume] in Serum or Plasma by Confirmatory method | Norfluvoxamine SerPl Cfm-mCnc | null | ACTIVE | 2.68 | 2.68 |
94298-7 | O-desmethylvenlafaxine | PrThr | Pt | Ser/Plas | Ord | Screen | DRUG/TOX | 1 | O-desmethylvenlafaxine [Presence] in Serum or Plasma by Screen method | ODV SerPl Ql Scn | null | ACTIVE | 2.68 | 2.69 |
94299-5 | Vilazodone | PrThr | Pt | Ser/Plas | Ord | Screen | DRUG/TOX | 1 | Vilazodone [Presence] in Serum or Plasma by Screen method | Vilaz SerPl Ql Scn | null | ACTIVE | 2.68 | 2.68 |
94-3 | Cefodizime | Titr | Pt | Isolate+Ser | Qn | SBT | ABXBACT | 1 | Cefodizime [Susceptibility] by Serum bactericidal titer | Cefodizime Titr SBT | null | ACTIVE | 1.0 | 2.32 |
9430-0 | Isobutylcarbinol | MCnc | Pt | Bld | Qn | null | DRUG/TOX | 1 | Isobutylcarbinol [Mass/volume] in Blood | Isobutylcarbinol Bld-mCnc | null | ACTIVE | 1.0i | 2.73 |
94300-1 | Vilazodone | MCnc | Pt | Ser/Plas | Qn | Confirm | DRUG/TOX | 1 | Vilazodone [Mass/volume] in Serum or Plasma by Confirmatory method | Vilaz SerPl Cfm-mCnc | null | ACTIVE | 2.68 | 2.68 |
94301-9 | Vortioxetine | PrThr | Pt | Ser/Plas | Ord | Screen | DRUG/TOX | 1 | Vortioxetine [Presence] in Serum or Plasma by Screen method | Vortioxetine SerPl Ql Scn | null | ACTIVE | 2.68 | 2.68 |
94302-7 | Vortioxetine | MCnc | Pt | Ser/Plas | Qn | Confirm | DRUG/TOX | 1 | Vortioxetine [Mass/volume] in Serum or Plasma by Confirmatory method | Vortioxetine SerPl Cfm-mCnc | null | ACTIVE | 2.68 | 2.68 |
94303-5 | Pregnenolone & 17-Hydroxypregnenolone panel | - | Pt | Ser/Plas | Qn | null | PANEL.CHEM | 1 | Pregnenolone and 17-Hydroxypregnenolone panel - Serum or Plasma | Preg + 17-OH Preg pnl SerPl | null | ACTIVE | 2.68 | 2.68 |
94304-3 | OxyCODONE & metabolites panel | - | Pt | Urine | - | Confirm | PANEL.DRUG/TOX | 1 | OxyCODONE and metabolites panel - Urine by Confirmatory method | OxyCODONE+metabolites Pnl Ur Cfm | null | ACTIVE | 2.68 | 2.68 |
94305-0 | OxyMORphone & Noroxymorphone panel | - | Pt | Urine | - | Confirm | PANEL.DRUG/TOX | 1 | OxyMORphone and Noroxymorphone panel - Urine by Confirmatory method | OxyMORphone+Noroxymorph Pnl Ur Cfm | null | ACTIVE | 2.68 | 2.68 |
94306-8 | SARS coronavirus 2 RNA panel | - | Pt | XXX | - | Probe.amp.tar | PANEL.MICRO | 1 | SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection | SARS-CoV-2 RNA Pnl Spec NAA+probe | null | ACTIVE | 2.68 | 2.69 |
94307-6 | SARS coronavirus 2 N gene | PrThr | Pt | XXX | Ord | Probe.amp.tar.CDC primer-probe set N1 | MICRO | 1 | SARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N1 | SARS-CoV-2 N gene Spec Ql NAA N1 | null | ACTIVE | 2.68 | 2.69 |
94308-4 | SARS coronavirus 2 N gene | PrThr | Pt | XXX | Ord | Probe.amp.tar.CDC primer-probe set N2 | MICRO | 1 | SARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N2 | SARS-CoV-2 N gene Spec Ql NAA N2 | null | ACTIVE | 2.68 | 2.69 |
94309-2 | SARS coronavirus 2 RNA | PrThr | Pt | XXX | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen by NAA with probe detection | SARS-CoV-2 RNA Spec Ql NAA+probe | null | ACTIVE | 2.68 | 2.73 |
943-1 | C Ab | PrThr | Pt | Ser/Plas^BPU | Ord | null | BLDBK | 1 | C Ab [Presence] in Serum or Plasma from Blood product unit | C Ab SerPl BPU Ql | null | ACTIVE | 1.0 | 2.73 |
94310-0 | SARS-related coronavirus N gene | PrThr | Pt | XXX | Ord | Probe.amp.tar.CDC primer-probe set N3 | MICRO | 1 | SARS-related coronavirus N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N3 | SARS-related CoV N Spec Ql NAA N3 | null | ACTIVE | 2.68 | 2.7 |
94311-8 | SARS coronavirus 2 N gene | ThreshNum | Pt | XXX | Qn | Probe.amp.tar.CDC primer-probe set N1 | MICRO | 1 | SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Specimen by Nucleic acid amplification using CDC primer-probe set N1 | SARS-CoV-2 N gene Ct Spec Qn NAA N1 | null | ACTIVE | 2.68 | 2.69 |
94312-6 | SARS coronavirus 2 N gene | ThreshNum | Pt | XXX | Qn | Probe.amp.tar.CDC primer-probe set N2 | MICRO | 1 | SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Specimen by Nucleic acid amplification using CDC primer-probe set N2 | SARS-CoV-2 N gene Ct Spec Qn NAA N2 | null | ACTIVE | 2.68 | 2.69 |
94313-4 | SARS-related coronavirus N gene | ThreshNum | Pt | XXX | Qn | Probe.amp.tar.CDC primer-probe set N3 | MICRO | 1 | SARS-related coronavirus N gene [Cycle Threshold #] in Specimen by Nucleic acid amplification using CDC primer-probe set N3 | SARS-related CoV N Ct Spec Qn NAA N3 | null | ACTIVE | 2.68 | 2.7 |
94314-2 | SARS coronavirus 2 RdRp gene | PrThr | Pt | XXX | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Specimen by NAA with probe detection | SARS-CoV-2 RdRp Spec Ql NAA+probe | null | ACTIVE | 2.68 | 2.69 |
94315-9 | SARS-related coronavirus E gene | PrThr | Pt | XXX | Ord | Probe.amp.tar | MICRO | 1 | SARS-related coronavirus E gene [Presence] in Specimen by NAA with probe detection | SARS-rel CoV E gene Spec Ql NAA+probe | null | ACTIVE | 2.68 | 2.69 |
94316-7 | SARS coronavirus 2 N gene | PrThr | Pt | XXX | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by NAA with probe detection | SARS-CoV-2 N gene Spec Ql NAA+probe | null | ACTIVE | 2.68 | 2.69 |
9431-8 | Isobutanol | MCnc | Pt | Bld | Qn | null | DRUG/TOX | 1 | Isobutanol [Mass/volume] in Blood | Isobutanol Bld-mCnc | null | ACTIVE | 1.0i | 2.73 |
94318-3 | Plan of care note | Find | Pt | {Setting} | Doc | Medical aid in dying | DOC.ONTOLOGY | 2 | Medical Aid in Dying Plan of care note | MAiD Plan of care note | null | ACTIVE | 2.68 | 2.68 |
94319-1 | Consultation note | Find | Pt | {Setting} | Doc | Medical aid in dying | DOC.ONTOLOGY | 2 | Medical Aid in Dying Consult note | MAiD Consult note | null | ACTIVE | 2.68 | 2.68 |
94320-9 | Procedure note | Find | Pt | {Setting} | Doc | Medical aid in dying | DOC.ONTOLOGY | 2 | Medical Aid in Dying procedure note | MAiD Procedure note | null | ACTIVE | 2.68 | 2.68 |
94321-7 | Note | Find | Pt | {Setting} | Doc | Medical aid in dying.team | DOC.ONTOLOGY | 2 | Medical Aid in Dying Team Note | MAiD Team Note | null | ACTIVE | 2.68 | 2.68 |
94322-5 | Note | Find | Pt | Telephone encounter | Doc | Medical aid in dying | DOC.ONTOLOGY | 2 | Medical Aid in Dying Telephone encounter Note | MAiD Phone Note | null | ACTIVE | 2.68 | 2.68 |
94323-3 | Conference note | Find | Pt | {Setting} | Doc | Wound, ostomy, and continence care.team | DOC.ONTOLOGY | 2 | Wound, Ostomy, and Continence Care Team Conference note | WOC Team Conf eval note | null | ACTIVE | 2.68 | 2.68 |
94324-1 | Care management note | Find | Pt | {Setting} | Doc | Orthopaedic surgery | DOC.ONTOLOGY | 2 | Orthopaedic surgery Care management note | Orthopaedic surgery Care management note | null | ACTIVE | 2.68 | 2.68 |
9432-6 | Isobutyl acetate | MCnc | Pt | XXX | Qn | null | DRUG/TOX | 1 | Isobutyl acetate [Mass/volume] in Specimen | Isobutyl Acetate Spec-mCnc | null | ACTIVE | 1.0i | 2.7 |
94327-4 | PhenX - human papillomavirus vaccine use protocol 100802 | - | Pt | ^Patient | - | PhenX | PANEL.PHENX | 2 | PhenX - human papillomavirus vaccine use protocol 100802 | PhenX - HPV vaccine use protocol | null | ACTIVE | 2.68 | 2.68 |
94328-2 | Patient health questionnaire 8 item total score | Score | Pt | ^Patient | Qn | Reported.PHQ | SURVEY.PHQ | 4 | Patient Health Questionnaire 8 item (PHQ-8) total score [Reported] | null | null | ACTIVE | 2.68 | 2.68 |
94329-0 | Patient Health Questionnaire 8 item | - | Pt | ^Patient | - | Reported.PHQ | PANEL.SURVEY.PHQ | 4 | Patient Health Questionnaire 8 item (PHQ-8) [Reported] | null | null | ACTIVE | 2.68 | 2.68 |
94330-8 | Processing comment | Find | Pt | Specimen | Nom | null | SPEC | 1 | Specimen Processing comment | Specimen Processing comment | null | TRIAL | 2.68 | 2.68 |
94331-6 | Collection procedure comment | Find | Pt | Specimen | Nom | null | SPEC | 1 | Specimen Collection procedure comment | Spec Collect proc comment | null | TRIAL | 2.68 | 2.68 |
94332-4 | Microsporidia sp 18S rRNA gene panel | - | Pt | XXX | - | Non-probe.amp.tar | PANEL.MICRO | 1 | Microsporidia sp 18S rRNA gene panel - Specimen by NAA with non-probe detection | Microsporidia 18S rRNA Pnl NAA+non-prb | null | ACTIVE | 2.68 | 2.69 |
94333-2 | Encephalitozoon sp 18S rRNA gene | PrThr | Pt | XXX | Ord | Non-probe.amp.tar | MICRO | 1 | Encephalitozoon sp 18S rRNA gene [Presence] in Specimen by NAA with non-probe detection | Encephalitozoon 18S rRNA Spec Ql NAA+prb | null | ACTIVE | 2.68 | 2.69 |
9433-4 | Isoflurane | MCnc | Pt | Bld | Qn | null | DRUG/TOX | 1 | Isoflurane [Mass/volume] in Blood | Isofl Bld-mCnc | null | ACTIVE | 1.0i | 2.7 |
94334-0 | Enterocytozoon bieneusi 18S rRNA gene | PrThr | Pt | XXX | Ord | Non-probe.amp.tar | MICRO | 1 | Enterocytozoon bieneusi 18S rRNA gene [Presence] in Specimen by NAA with non-probe detection | E bieneusi 18S rRNA Spec Ql NAA+non-prb | null | ACTIVE | 2.68 | 2.69 |
94335-7 | Desmoglein 1 & Desmoglein 3 Ab.IgG panel | - | Pt | Ser | Qn | IA | PANEL.SERO | 1 | Desmoglein 1 and Desmoglein 3 IgG panel - Serum by Immunoassay | Desmoglein 1+3 IgG Pnl Ser IA | null | ACTIVE | 2.68 | 2.68 |
94336-5 | Desmoglein 1 Ab.IgG | ACnc | Pt | Ser | Qn | IA | SERO | 1 | Desmoglein 1 IgG Ab [Units/volume] in Serum by Immunoassay | Desmoglein 1 IgG Ser IA-aCnc | null | ACTIVE | 2.68 | 2.68 |
94337-3 | Desmoglein 3 Ab.IgG | ACnc | Pt | Ser | Qn | IA | SERO | 1 | Desmoglein 3 IgG Ab [Units/volume] in Serum by Immunoassay | Desmoglein 3 IgG Ser IA-aCnc | null | ACTIVE | 2.68 | 2.68 |
94338-1 | Chromosome 13+15+16+18+21+22+X+Y aneuploidy | Find | Pt | POC | Doc | FISH | MOLPATH | 1 | Chromosome 13+15+16+18+21+22+X+Y aneuploidy in Products of Conception by FISH | Chr 13+15+16+18+21+22+X+Y aneup POC FISH | null | ACTIVE | 2.68 | 2.68 |
94339-9 | Myelopathy autoimmune Ab panel | - | Pt | Ser | - | null | PANEL.SERO | 1 | Myelopathy autoimmune Ab panel - Serum | Myelopathy Ab pnl Ser | null | ACTIVE | 2.68 | 2.68 |
94340-7 | Amphiphysin Ab.IgG | Titr | Pt | Ser | Qn | IF | SERO | 1 | Amphiphysin IgG Ab [Titer] in Serum by Immunofluorescence | Amphiphysin IgG Titr Ser IF | null | ACTIVE | 2.68 | 2.68 |
94341-5 | Glial nuclear type 1 Ab.IgG | Titr | Pt | Ser | Qn | IF | SERO | 1 | Glial nuclear type 1 IgG Ab [Titer] in Serum by Immunofluorescence | Glial nuc type 1 IgG Titr Ser IF | null | ACTIVE | 2.68 | 2.68 |
9434-2 | Isopropanol | MCnc | Pt | Urine | Qn | null | DRUG/TOX | 1 | Isopropanol [Mass/volume] in Urine | Isopropanol Ur-mCnc | null | ACTIVE | 1.0i | 2.73 |
94342-3 | Neuronal nuclear type 1 Ab.IgG | Titr | Pt | Ser | Qn | IF | SERO | 1 | Neuronal nuclear type 1 IgG Ab [Titer] in Serum by Immunofluorescence | Hu1 IgG Titr Ser IF | null | ACTIVE | 2.68 | 2.68 |
94343-1 | Neuronal nuclear type 2 Ab.IgG | Titr | Pt | Ser | Qn | IF | SERO | 1 | Neuronal nuclear type 2 IgG Ab [Titer] in Serum by Immunofluorescence | Hu2 IgG Titr Ser IF | null | ACTIVE | 2.68 | 2.68 |
94344-9 | Neuronal nuclear type 3 Ab.IgG | Titr | Pt | Ser | Qn | IF | SERO | 1 | Neuronal nuclear type 3 IgG Ab [Titer] in Serum by Immunofluorescence | Hu3 IgG Titr Ser IF | null | ACTIVE | 2.68 | 2.68 |
94345-6 | Glutamate decarboxylase 65 Ab.IgG+IgM | SCnc | Pt | Ser | Qn | IA | SERO | 1 | Glutamate decarboxylase 65 IgG+IgM Ab [Moles/volume] in Serum by Immunoassay | GAD65 IgG+IgM Ser IA-sCnc | null | ACTIVE | 2.68 | 2.68 |
Subsets and Splits
No saved queries yet
Save your SQL queries to embed, download, and access them later. Queries will appear here once saved.